PHOSPHORAMIDEMUSTARD
中文名称 | PHOSPHORAMIDEMUSTARD |
---|---|
中文同义词 | PHOSPHAMIDE MUSTARD CYCLOHEXAMINE SALT;磷酰胺氮芥环己盐;N,N-双(2-氯乙基)磷二酰胺酸环己胺盐;N,N-BIS(2-CHLOROETHYL)PHOSPHORODIAMIDIC ACID COMPOUND WITH CYCLOHEXANAMINE (1:1) |
英文名称 | PHOSPHORAMIDEMUSTARD |
英文同义词 | Ai3-51834;Phosphorodiamidic acid, N,N-bis(2-chloroethyl)-, compd. with cyclohexanamine(1:1) (9ci);Phosphorodiamidic acid, N,N-bis(2-chloroethyl)-, compound with cyclohexanamine (1:1);N,N-Bis(2-chloroethyl)phosphorodiaMidic Acid CyclohexylaMine Salt;amino-[bis(2-chloroethyl)amino]phosphinic acid,cyclohexanamine;Phosphamide Mustard;Phosphamide Mustard Cyclohexamine Salt;Phosphoramide mustard cyclohexylammonium salt |
CAS号 | 1566-15-0 |
分子式 | C10H24Cl2N3O2P |
分子量 | 320.196221 |
EINECS号 | |
相关类别 | Amino Acids & Derivatives, Heterocycles, Metabolites & Impurities, Pharmaceuticals, Intermediates & Fine Chemicals |
Mol文件 | 1566-15-0.mol |
结构式 |
PHOSPHORAMIDEMUSTARD 性质
熔点 | 100-103°C |
---|---|
储存条件 | Hygroscopic, -20°C Freezer, Under inert atmosphere |
溶解度 | 可溶于氯仿(少许)、甲醇(少许) |
形态 | 固体 |
颜色 | 白色至类白色 |
稳定性 | 湿气敏感 |
Phosphoramide mustard cyclohexanamine causes cytotoxicity through forming cross-linked DNA adducts which inhibit DNA strand separation during replication.
Phosphoramide mustard cyclohexanamine (3-6 μM; 48 hours) reduces cell viability in rat spontaneously immortalized granulosa cells (SIGCs).
Phosphoramide mustard cyclohexanamine (3-6 μM; 24-48 hours) induces DNA adduct formation and ovarian DNA damage.
Phosphoramide mustard cyclohexanamine (3-6 μM; 24-48 hours) increases DNA damage responses (DDR) gene mRNA expression levels and DDR proteins.
Cell Viability Assay
Cell Line: | SIGCs |
Concentration: | 0.5 μM, 1 μM, 3 μM, 6 μM |
Incubation Time: | 48 hours |
Result: | Reduced cell viability at concentrations of 3 μM and higher. |
RT-PCR
Cell Line: | SIGCs |
Concentration: | 3 μM, 6 μM |
Incubation Time: | 24 hours, 48 hours |
Result: | Increased DDR gene mRNA expression levels. |
Western Blot Analysis
Cell Line: | SIGCs |
Concentration: | 3 μM, 6 μM |
Incubation Time: | 24 hours, 48 hours |
Result: | Generally increased DDR proteins. |
Phosphoramide mustard cyclohexanamine (2.1-20.7 mg/kg; i.p.; daily; for 5 days) inhibits subcutaneous tumor growth in rats.
Phosphoramide mustard cyclohexanamine exhibits terminal elimination half-lives (rat 15.1 min) following intravenous administration (rat 59.4 mg/kg).
Animal Model: | Rat, subcutaneously implanted Walker 256 carcinosarcoma tumor |
Dosage: | 2.1 mg/kg, 4.8 mg/kg, 10.4 mg/kg, 20.7 mg/kg |
Administration: | Intraperitoneal injection, once daily, for 5 consecutive days |
Result: | Required to produce 50% inhibition of subcutaneous tumor growth with dose of 12 mg/kg. |
Animal Model: | Rats |
Dosage: | 86.0 mg/kg (Pharmacokinetic Analysis) |
Administration: | Intravenous injection |
Result: | T 1/2 (15.1 min). |